TY  - RPRT
TI  - APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancer
AU  - Garcia, N. M. G.
AU  - Becerra, J. N.
AU  - McKinney, B. J.
AU  - DiMarco, A. V.
AU  - Wu, F.
AU  - Fitzgibbon, M.
AU  - Alvarez, J. V.
PY  - 2023
DO  - 10.1101/2023.07.02.547443
UR  - https://www.biorxiv.org/content/10.1101/2023.07.02.547443v1
ID  - 10.1101/2023.07.02.547443
ER  -